세계의 오스테오바이오로직스 시장 : 제품, 기술, 가공 방법, 공급 재료, 용도, 최종 사용자별 예측(2025-2030년)

The Osteobiologics Market was valued at USD 1.29 billion in 2023, expected to reach USD 1.36 billion in 2024, and is projected to grow at a CAGR of 5.47%, to USD 1.88 billion by 2030.

Osteobiologics, a subset of the broader biomaterials market, encompass products that promote bone healing, regeneration, and repair. These include bone graft substitutes, growth factors, and cellular scaffolds, playing crucial roles in orthopedic and dental surgeries. The demand for osteobiologics is driven by the rising prevalence of bone disorders such as osteoporosis and osteoarthritis, the growing aging population, and advancements in surgical procedures. Key applications lie in spinal fusion, trauma fixation, and reconstructive surgeries where natural bone healing is insufficient. Hospitals, specialized clinics, and research institutions comprise the primary end-users of osteobiologics products. Significant market growth factors include technological advancements in material science and bioengineering, increased investment in research and development, and a rising focus on minimally invasive surgical techniques. Opportunities are emerging from developing synthetic bone grafts that mimic natural bone properties more closely and innovations in 3D printing technology for customized implants. Recommendations include focusing on robust product pipeline development to address unmet clinical needs and pursuing strategic partnerships with healthcare institutions for enhanced market penetration. However, challenges such as the high cost of osteobiologic products, stringent regulatory frameworks, and the risk of immune response or rejection limit market growth. Furthermore, complexities related to product standardization and long approval timelines impede rapid innovation. To overcome these barriers, companies should invest in cost-effective manufacturing technologies and engage in collaborative R&D to streamline regulatory approvals. The nature of this market is highly competitive, with a strong emphasis on scientific advancement and increased consumer awareness about the benefits of osteobiologics. There is considerable scope for innovation in bioactive materials and mixed-use therapies combining biological and synthetic components for superior outcomes, presenting lucrative avenues for market expansion and differentiation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Osteobiologics Market

The Osteobiologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing aging population globally and rising prevalence of bone-related conditions
  • Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
  • Growing demand for minimally invasive treatments
• Market Restraints
  • Variability in clinical outcomes affecting the credibility and acceptance of products
• Market Opportunities
  • Development of patient-specific treatments using 3D printing and tissue engineering
  • Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
• Market Challenges
  • Limited awareness and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Osteobiologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Osteobiologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Osteobiologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Osteobiologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Osteobiologics Market

A detailed market share analysis in the Osteobiologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Osteobiologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Osteobiologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Osteobiologics Market

A strategic analysis of the Osteobiologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteobiologics Market, highlighting leading vendors and their innovative profiles. These include Advancells Diagnostics, Aetna Inc., AlloSource, Anika Therapeutics, Inc., Arthrex, Inc., Australian Biotechnologies Pty Ltd, Baxter International Inc., Biogennix, LLC., CONMED Corporation, Exactech, Inc.(parent company TPG Capital), Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, KLS Martin Group, KNITPRO INTERNATIONAL, Medical Device Business Services, Inc., Medtronic Plc, MTF Biologics, NuVasive, Inc., Orthofix Medical Inc., Osiris Therapeutics, Inc. (acquired by Smith & Nephew), ROYAL BIOLOGICS, RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP), Stryker Corporation, SynerHeal Pharmaceuticals, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Osteobiologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Allografts, Bone Marrow Aspirate Concentrate, Bone Morphogenic Protein, Demineralized Bone Matrices, Plasma-Rich Protein, Synthetic Orthobiologics, and Visco-Supplementation Products.
• Based on Technique, market is studied across Bioceramics & Composites, Injectable Biomaterials, and Orthopedic Biomaterial Implants.
• Based on Processing Method, market is studied across Demineralized, Mineralized, Osteoconductive, and Osteoinductive.
• Based on Material Sourced, market is studied across Natural and Synthetic.
• Based on Application, market is studied across Bone Infection & Tumors, Dental Bone Grafting, Joint Reconstruction, Spinal Fusion, and Trauma & Non-Union Fractures.
• Based on End-User, market is studied across Hospitals, Research & Academic Institutes, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing aging population globally and rising prevalence of bone-related conditions
    • 5.1.1.2. Rising surgical interventions involving bones and joints necessitating advanced bone healing solutions
    • 5.1.1.3. Growing demand for minimally invasive treatments
  • 5.1.2. Restraints
    • 5.1.2.1. Variability in clinical outcomes affecting the credibility and acceptance of products
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of patient-specific treatments using 3D printing and tissue engineering
    • 5.1.3.2. Expansion of product lines to include novel materials and combinations of biological agents for enhanced efficacy
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and dearth of skilled professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging usage of allografts owing to their osteoconductive properties that support new bone growth
  • 5.2.2. Application: Need for osteobiologic solutions that combine antimicrobial and regenerative properties for targeting bone infection & tumors
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Osteobiologics Market, by Product

• 6.1. Introduction
• 6.2. Allografts
• 6.3. Bone Marrow Aspirate Concentrate
• 6.4. Bone Morphogenic Protein
• 6.5. Demineralized Bone Matrices
• 6.6. Plasma-Rich Protein
• 6.7. Synthetic Orthobiologics
• 6.8. Visco-Supplementation Products

7. Osteobiologics Market, by Technique

• 7.1. Introduction
• 7.2. Bioceramics & Composites
• 7.3. Injectable Biomaterials
• 7.4. Orthopedic Biomaterial Implants

8. Osteobiologics Market, by Processing Method

• 8.1. Introduction
• 8.2. Demineralized
• 8.3. Mineralized
• 8.4. Osteoconductive
• 8.5. Osteoinductive

9. Osteobiologics Market, by Material Sourced

• 9.1. Introduction
• 9.2. Natural
• 9.3. Synthetic

10. Osteobiologics Market, by Application

• 10.1. Introduction
• 10.2. Bone Infection & Tumors
• 10.3. Dental Bone Grafting
• 10.4. Joint Reconstruction
• 10.5. Spinal Fusion
• 10.6. Trauma & Non-Union Fractures

11. Osteobiologics Market, by End-User

• 11.1. Introduction
• 11.2. Hospitals
• 11.3. Research & Academic Institutes
• 11.4. Specialty Clinics

12. Americas Osteobiologics Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Osteobiologics Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Osteobiologics Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Biogennix launches Agilon Surgical Matrix made from bovine collagen
  • 15.3.2. Biogennix receives FDA clearance for Agilon and Morpheus Moldable products
  • 15.3.3. Irvine-based biogennix launches osteospan fiber matrix to enhance surgical outcomes
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advancells Diagnostics
• 2. Aetna Inc.
• 3. AlloSource
• 4. Anika Therapeutics, Inc.
• 5. Arthrex, Inc.
• 6. Australian Biotechnologies Pty Ltd
• 7. Baxter International Inc.
• 8. Biogennix, LLC.
• 9. CONMED Corporation
• 10. Exactech, Inc.(parent company TPG Capital)
• 11. Geistlich Pharma AG
• 12. Integra LifeSciences Holdings Corporation
• 13. KLS Martin Group
• 14. KNITPRO INTERNATIONAL
• 15. Medical Device Business Services, Inc.
• 16. Medtronic Plc
• 17. MTF Biologics
• 18. NuVasive, Inc.
• 19. Orthofix Medical Inc.
• 20. Osiris Therapeutics, Inc. (acquired by Smith & Nephew)
• 21. ROYAL BIOLOGICS
• 22. RTI Surgical Holdings, Inc.(acquired by Montagu Private Equity LLP)
• 23. Stryker Corporation
• 24. SynerHeal Pharmaceuticals
• 25. Wright Medical Group N.V.
• 26. Zimmer Biomet Holdings, Inc.